ArticleslgStudy

biology

Subependymal giant cell astrocytoma

Subependymal giant cell astrocytoma is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Subependymal giant cell astrocytoma rather than just read about it. In short: Subependymal giant cell astrocytoma (SEGA, SGCA, or SGCT) is a low-grade astrocytic brain tumor (astrocytoma) that arises within the ventricles of the brain. It is most commonly associated with tuberous sclerosis complex (TSC).

Subependymal giant cell astrocytoma — main illustration
Subependymal giant cell astrocytoma — illustration

Key takeaways

  • Subependymal giant cell astrocytoma belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Subependymal giant cell astrocytoma to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Subependymal giant cell astrocytoma from memory before moving on to harder problems.

Reference excerpt

Subependymal giant cell astrocytoma (SEGA, SGCA, or SGCT) is a low-grade astrocytic brain tumor (astrocytoma) that arises within the ventricles of the brain. It is most commonly associated with tuberous sclerosis complex (TSC). Although it is a low-grade tumor, its location can potentially obstruct the ventricles and lead to hydrocephalus.

Signs and symptoms Individuals with this type of tumor may have no symptoms if cerebrospinal fluid (CSF) flow remains open. Obstruction of CSF flow will result in the symptoms associated with increased CSF pressure: nausea, vomiting, headache (often positional), lethargy, blurry or double vision, new or worsened seizures, and personality change.

Diagnosis

Diagnosis is made by imaging with a contrast-enhanced MRI or CT scan of the brain.

Screening It is recommended that children with TSC be screened for SEGA with neuroimaging every 1–3 years.

Treatment

Pharmacotherapy Two related drugs have been shown to shrink or stabilize subependymal giant cell tumors: rapamycin and everolimus. These both belong to the mTOR inhibitor class of immunosuppressants, and are both contraindicated in patients with severe infections. Rapamycin showed efficacy in five cases of SEGA in TSC patients, shrinking their tumor volumes by an average of 65%. However, after the drug was stopped, the tumors regrew. Everolimus, which has a similar structure as rapamycin, but with slightly increased bioavailability and shorter half-life, was studied in 28 patients with SEGA. There was a significant reduction in SEGA size in 75% of the patients, and a mild improvement in their seizures. Everolimus was approved for the treatment of SEGA by the US Food and Drug Administration (FDA) in October, 2010.

Surgery

A NIH Consensus Conference report in 1999 recommends that any SEGA that is growing or causing symptoms should be surgically removed. Tumors are also removed in cases where a patient is suffering from a high seizure burden. If a tumor is rapidly growing or causing symptoms of hydrocephalus, deferring surgery may lead to vision loss, need for ventricular shunt, and ultimately death. Total removal of the tumor is curative. Surgery to remove intraventricular tumors also carries risks of complications or death. Potential complications include transient memory impairment, hemiparesis, infection, chronic ventriculoperitoneal shunt placement, stroke, and death.

Prognosis After complete surgical removal, a SEGA tumor does not grow back. They do not metastasize to other parts of the body. However, the patient is still at risk for, and often develops, new tumors arising from subependymal nodules elsewhere in the ventricular system.

Epidemiology SEGAs arise in 5-20% of TSC patients.

References

External links

Illustrations

Subependymal giant cell astrocytoma illustration
Subependymal giant cell astrocytoma: MRI of brain with sub-ependymal giant cell astrocytoma
MRI of brain with sub-ependymal giant cell astrocytoma
Subependymal giant cell astrocytoma: Photograph of a brain section containing a subependymal giant cell astrocytoma
Photograph of a brain section containing a subependymal giant cell astrocytoma

Worked examples

Example 1 — a first encounter with Subependymal giant cell astrocytoma

Start with the simplest possible case. Write down what Subependymal giant cell astrocytoma claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Subependymal giant cell astrocytoma before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Subependymal giant cell astrocytoma ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Subependymal giant cell astrocytoma

In research
Subependymal giant cell astrocytoma appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Subependymal giant cell astrocytoma in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Subependymal giant cell astrocytoma is common in secondary-school and first-year university syllabi. It links to neighbouring topics Benign neoplasms, Brain tumor, so understanding it makes those chapters shorter.
In everyday life
Look for Subependymal giant cell astrocytoma outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Subependymal giant cell astrocytoma” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Subependymal giant cell astrocytoma in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Subependymal giant cell astrocytoma means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Subependymal giant cell astrocytoma out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Subependymal giant cell astrocytoma in simple terms?

Subependymal giant cell astrocytoma (SEGA, SGCA, or SGCT) is a low-grade astrocytic brain tumor (astrocytoma) that arises within the ventricles of the brain. It is most commonly associated with tuberous sclerosis complex (TSC).

Why does Subependymal giant cell astrocytoma matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Subependymal giant cell astrocytoma?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Subependymal giant cell astrocytoma.

Tags

  • Benign neoplasms
  • Brain tumor

Keep exploring